Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004134 (
ataxia
)
15,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using whole-exome sequencing, we identified seven unrelated individuals with global developmental delay, hypotonia, dysmorphic facial features, and an increased frequency of short stature,
ataxia
, and autism with de novo heterozygous frameshift, nonsense, splice, and missense variants in the
Early B-cell Transcription Factor Family Member 3
(
EBF3
) gene. EBF3 is a member of the collier/olfactory-1/
early B-cell factor
(COE) family of proteins, which are required for central nervous system (CNS) development. COE proteins are highly evolutionarily conserved and regulate neuronal specification, migration, axon guidance, and dendritogenesis during development and are essential for maintaining neuronal identity in adult neurons. Haploinsufficiency of
EBF3
may affect brain development and function, resulting in developmental delay, intellectual disability, and behavioral differences observed in individuals with a deleterious variant in
EBF3
.
...
PMID:De novo variants in
EBF3
are associated with hypotonia, developmental delay, intellectual disability, and autism. 2916 53